GLP-1 Therapies Research,
some of our latest newsletters:
(select one to read it below)
GLP-1 drugs cut sepsis risk by 37% and may strengthen bones, protect the brain, and curb addiction
The Ozempic generation is reshaping medicine in unexpected ways. New research reveals these popular weight-loss drugs may have protective effects far beyond diabetes and obesity—from reducing serious surgical complications to potentially helping with depression and addiction.
🏥 GLP-1 drugs slash surgical complications in major study
Analysis of 365,154 joint replacement patients found those on GLP-1 drugs (like Ozempic) had 14% lower readmission rates and 37% lower sepsis risk compared to non-users
The sepsis protection was strongest in shoulder replacement patients, with GLP-1 users showing a 56% reduction in this life-threatening infection
Hospital stays were also slightly shorter for GLP-1 users, with no increase in blood clots or other surgical complications
Why it matters: This suggests GLP-1 drugs may have anti-inflammatory effects that extend well beyond weight loss, potentially making surgery safer for millions of patients.
Also in this issue:
- 🦴 Spine surgery patients see surprising bone healing benefits
- 🧠 Brain protection extends to neurodegenerative diseases
- 🍔 Addiction research reveals appetite control goes beyond food
- 💊 Dual-action drugs show superior liver benefits
- ⚖️ Access inequality raises ethical concerns
- 🔬 New hormone offers complementary approach
Want to read the full story?
This is a preview of our Pro newsletter. Subscribe to get every issue delivered to your inbox.
Subscribe NowScience is the only real news.
The rest is just drama 📰
And nowadays, we see that drama everywhere.
Drama sells ads, ads sell products, and my attention sells to the highest bidder.
Drama media is junk food for the mind.
A quick rush, hard to avoid, but little nutritional value.
The brain wants broccoli 🧠🥦
And look, it's not that science never makes the news.
But think about when it does—does the news really understand the science it reports on?
Like it or not, AI exists now.
And it happens to be a huge science nerd… 🔭🤖
…with a superpower…
...unlike an average science nerd, AI can explain it simply.
I built OpenScience to make the constant stream of new studies accessible to anyone.
To free science from academic jargon and tiny-fonted PDFs.
OpenScience is a weekly newsletter of 7 compelling studies from the past week in the topic of your choice.
Made simple, digestible, and delightful by AI.
Interested in CRISPR?
The latest Long Covid research?
Psychedelic medicine?
Follow the actual science, as it comes out.
Every study is linked to the original PubMed so you can verify the AI's summary yourself.
Not supported by ads. Your attention is not the product.
My goal is for the science itself to be the product—and for that to be worth paying for.
Start your free trial in a topic of your choice today—and give your mind the broccoli it deserves 🥦
The real-time unfolding of science is too interesting not to follow.
The past week's glp-1 therapies research—translated into simple language by AI.
- $4/month for weekly issues
- 4 free issues to start
- 1st issue of the month is free to everyone